Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
MYLAN's MAXZIDE SALES NOW ANNUALIZING AT MORE THAN $60 MIL
Aug 04 1986
•
By
The Pink Sheet
More from Archive
More from Pink Sheet